Yun-Long Li,Andrew P. Combs,Eddy W. Yue,Thomas P. Maduskuie, Jr.,Richard B. Sparks
申请号：
US15351592
公开号：
US09815839B2
申请日:
2016.11.15
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The present invention provides N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines derivatives that modulate the activity of phosphoinositide 3-kinases (PI3Ks) and are useful in the treatment of diseases related to the activity of PI3Ks including, for example, inflammatory disorders, immune-based disorders, cancer, and other diseases.
